Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JUNE 29, 2015

Second, the main goal of PE investors is to increase a firm’s value so that it can be sold for profit. And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

MARCH 18, 2018

In fact, by government edict, the goal is to direct policy, health care, and even citizens themselves toward longer, healthier, more enriching lives. Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. By country, Japan had 9.1

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 53

Resources Industry System Strategy 53

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. It’s like that. It doesn’t have to be this way. You can see why: For decades in the U.S.,

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. When predefined treatment goals are attained, both parties contractually benefit. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. Innovators developing new drugs, devices, and procedures should look beyond profits alone and incorporate the need to add value into their investments.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. And providers want the flexibility to deliver outcomes in the best, most innovative, and most efficient way possible without being micromanaged by the customer. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 15, 2014

A big goal requires a “thick we” network — a community of people who feel responsible for collaborating toward a shared purpose that they see as superseding their individual needs. Consider Ashoka , which provides start-up funding and support for social innovators worldwide. Participants tend to belong for individualistic reasons.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

DECEMBER 14, 2015

He says he’s seeing a growing interest among leaders in meditation as a way to build leadership skills – and achieve business goals. They want to see how these approaches … are truly beneficial to existing priorities like retention, talent advancement, innovation.” The trading desk was an organized riot.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Another way for new entrants to turn customers into advocates is by seeking support from existing consumer organizations whose goals align with those of the firm. In the U.S.,

Licensing 10

Licensing Proposal Retail Long-term 10

Harvard Business Review

JANUARY 30, 2014

Instead of supporting employees already undertaking their own self-improvement plans and encouraging others to start them, wellness has morphed in many directions that increasingly overlook or even conflict with that original goal. Second, wellness has become a marketing tool for health plans, nowhere more so than at Aetna.

Human Resources 10

Human Resources Guidelines Morale Insurance 10

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 68

Execution Company 360-Degree Feedback Cooper 68

Harvard Business Review

JUNE 21, 2017

Precision medicine innovations are driven by complex analysis of massive data sets, with researchers querying data derived from thousands of patients for each cancer type. How the most innovative providers are creating value. Insight Center. The Leading Edge of Health Care. Sponsored by Optum.

Metrics 8

Metrics Health Care Learning-by-Doing Education 8

Harvard Business Review

JUNE 23, 2015

maintaining alignment with the company’s corporate goals. Teams are hurt by unclear governance, by a lack of accountability, by goals that lack specificity, and by organizations’ failure to prioritize the success of cross-functional projects. Every project should have clearly established goals, resources, and deadlines.

Team 8

Team Project Software Engineering 8

Harvard Business Review

SEPTEMBER 5, 2016

Yet there’s compelling evidence that bureaucracy creates a significant drag on productivity and organizational resilience and innovation. The goal, of course, isn’t to put 21.4 More people are working in big, bureaucratic organizations than ever before. By our reckoning, the cost of excess bureaucracy in the U.S.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

NOVEMBER 3, 2017

However, beyond the strategic goal of becoming an industry leader in terms of cost structure, there was no “story” for how this effort would complement the business’s broader ambitions. The company defined a new growth strategy that would require a significant improvement in its ability to innovate rapidly.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

OCTOBER 25, 2018

Traditionally, organizations have used data analytics as a tool of retrospection, as a means of answering questions like, “Did this marketing campaign reach our desired audience?” A history of maximizing pageviews is not itself a compelling reason to set a renewed goal of maximizing pageviews. ” Insight Center.

How To 11

How To Pharmaceuticals Process Objective 11

Harvard Business Review

MAY 12, 2011

Instead of a pharmaceutical industry, I see a new set of mental and physical discontents, like rates of suspiciously normally "abnormal" mental illnesses and drugs whose lists of "side effects" are longer than the Magna Carta. I see, instead of food and education "industries," an obesity epidemic and a debt-driven education crisis.

GDP 21

GDP Hamel Industry Construction 21

Harvard Business Review

OCTOBER 8, 2013

Today, payers and providers are using a range of strategies to accomplish this goal, including patient-centered medical homes , value-based contracting , and accountable care organizations (ACOs). pharmaceuticals, physical therapy, skilled nursing facility care). The vexing question is how best to make this transition.

Health Care 8

Health Care Cost Analysis Competitive Advantage 8